Check out our most popular compounded medications! Get Started
Imiquimod 5%/Diclofenac Sodium 1% Topical Cream is a semisolid preparation, dispensed via a pump mechanism for easy and controlled application. This formulation is designed for localized treatment of skin conditions such as Actinic Keratosis, Basal Cell Carcinoma, Bowen's Disease, Squamous Cell Carcinoma, and Molluscum Contagiosum.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Imiquimod 5%/Diclofenac Sodium 1% Topical Cream is a compounded formulation designed to treat a range of skin conditions. This includes Actinic Keratosis, Basal Cell Carcinoma, Bowen's Disease, Squamous Cell Carcinoma, and Molluscum Contagiosum. The cream is a semisolid preparation dispensed in a pump mechanism, which allows for convenient and controlled application on the skin for localized treatment or absorption of active ingredients.
The cream contains two active ingredients: Imiquimod and Diclofenac Sodium. Imiquimod is an immune response modifier that stimulates the body's own immune system to combat the skin condition. On the other hand, Diclofenac Sodium is an anti-inflammatory that aids in reducing inflammation and pain associated with the skin condition.
It is crucial to follow your healthcare provider's instructions when using Imiquimod 5%/Diclofenac Sodium 1% Topical Cream. Common side effects may include redness, itching, burning, and irritation at the application site. If you experience any severe side effects, it is important to contact your healthcare provider immediately.
At Bayview Pharmacy, we are dedicated to providing our patients with the highest quality of care. If you have any questions about Imiquimod 5%/Diclofenac Sodium 1% Topical Cream or any other medications, please do not hesitate to reach out to us. We are here to assist you with your healthcare needs.
Imiquimod 5%/Diclofenac Sodium 1% Topical Cream is a compounded formulation designed for the treatment of various skin conditions including actinic keratosis, basal cell carcinoma, Bowen's disease, squamous cell carcinoma, and molluscum contagiosum. This cream combines the potent effects of Imiquimod, an immune response modifier, and Diclofenac Sodium, a nonsteroidal anti-inflammatory drug (NSAID).
Imiquimod works by stimulating the body's own immune system to combat the virus that causes molluscum contagiosum. On the other hand, Diclofenac Sodium reduces inflammation and pain. When used in combination, these two active ingredients can effectively reduce the size and number of lesions caused by the aforementioned skin conditions.
The cream is dispensed in a pump mechanism, which allows for convenient and controlled application on the skin. It is designed for localized treatment, ensuring that the active ingredients are absorbed precisely where they are needed. Patients are advised to apply the cream to the affected area twice daily for a period of up to 16 weeks.
It is crucial to avoid applying the cream on broken or irritated skin. Additionally, contact with the eyes, nose, and mouth should be avoided. Common side effects of Imiquimod 5%/Diclofenac Sodium 1% Topical Cream include redness, itching, burning, and irritation at the application site. If any of these side effects occur, patients are advised to contact their healthcare provider immediately.
Imiquimod 5%/Diclofenac Sodium 1% Topical Cream is a powerful tool in the treatment of various skin conditions. However, it is important to use it as directed by a healthcare provider to ensure its effectiveness and safety.
Imiquimod 5%/Diclofenac Sodium 1% Topical Cream is a compounded formulation that combines the therapeutic benefits of two active ingredients, Imiquimod and Diclofenac Sodium, to treat a range of skin conditions. This topical cream is dispensed in a pump mechanism for easy and controlled application directly on the affected skin area.
Imiquimod, an immune response modifier, stimulates the body's immune system to combat infections or diseases. Diclofenac Sodium, a non-steroidal anti-inflammatory drug (NSAID), complements the action of Imiquimod by reducing inflammation and pain associated with these conditions.
In each of these conditions, the cream works by stimulating the body's immune system to fight the infection and reduce symptoms.
Imiquimod 5%/Diclofenac Sodium 1% Topical Cream is a appropriate treatment option for these skin conditions. However, it is crucial to use this medication as directed by your healthcare provider. If you have any questions or concerns about the use of this medication, do not hesitate to seek professional advice.
This compounded formulation of Imiquimod 5%/Diclofenac Sodium 1% Topical Cream is a semisolid preparation dispensed in a pump mechanism, designed for convenient and controlled application on the skin. It is primarily used for localized treatment or absorption of active ingredients. This formulation has been effectively used to treat a variety of skin conditions, including Actinic Keratosis, Basal Cell Carcinoma, Bowen's Disease, Squamous Cell Carcinoma, and Molluscum Contagiosum. It has also shown efficacy in treating other skin conditions such as warts, psoriasis, and actinic cheilitis.
It has also been used to reduce the size of skin lesions and to reduce the risk of scarring. This formulation has been found to be well tolerated and has minimal side effects. However, patients should be aware that this formulation may cause skin irritation, redness, and itching. It may also cause a burning sensation when applied to the skin.
Patients should contact their healthcare provider if they experience any of these side effects. Prescribers should be aware that this formulation should not be used in patients with a known hypersensitivity to either Imiquimod or Diclofenac Sodium. If you have any questions about this formulation, please reach out to your healthcare provider.
This is a compounded formulation of two active ingredients, Imiquimod and Diclofenac Sodium, designed for topical application. It is a semisolid preparation dispensed in a pump mechanism for convenient and controlled application on the skin.
The pump mechanism is designed to provide a convenient and controlled application of the cream on the skin. It ensures that the right amount of cream is dispensed each time.
The active ingredients in this cream are Imiquimod (5%) and Diclofenac Sodium (1%).
Imiquimod is an immune response modifier. It works by stimulating the body's natural defense mechanisms and is commonly used to treat certain types of skin conditions.
Diclofenac Sodium is a nonsteroidal anti-inflammatory drug (NSAID) that works by reducing substances in the body that cause pain and inflammation. It is used to treat mild to moderate pain, or signs and symptoms of osteoarthritis or rheumatoid arthritis.
This cream should be applied topically to the affected area as directed by your healthcare provider. The pump mechanism allows for a controlled application.
Before using this cream, it is important to discuss your skin type and any skin conditions you may have with your healthcare provider. They will be able to advise if this cream is suitable for your specific needs.
As with any medication, there can be side effects. Common side effects may include skin irritation, redness, or swelling at the application site. If you experience any severe or persistent side effects, you should contact your healthcare provider immediately.
Before starting any new medication, it is important to discuss with your healthcare provider. They will be able to advise you on whether it is safe to use this cream with other medications.
This cream should be stored at room temperature, away from heat and direct light. Do not freeze. Keep out of the reach of children and pets.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
The conditions listed on this page are indications prescribers have ordered this preparation for. They are not FDA-approved indications, and listing them is not a statement that this preparation is effective for them.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice — discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Apply topically to affected area(s)
